News Focus
News Focus
Replies to #73879 on Biotech Values
icon url

DewDiligence

03/03/09 8:49 PM

#73899 RE: tinkershaw #73879

Today’s FDA approval of Copaxone in CIS has only a very slight consequence for MNTA. It’s doubtful that many investors thought this news per se was a reason to buy.